Karyopharm Therapeutics Inc. (NASDAQ: KPTI) - quick read on what's happening inside the company
Bottom line: management is executing cost cuts and advancing Phase 3 programs while simultaneously running short on liquidity and facing heavy debt maturities and covenants. The company has announced B...